ERNA logo

Ernexa Therapeutics Inc. (ERNA)

Profile

Full Name

Ernexa Therapeutics Inc.

Ticker

NASDAQ: ERNA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

August 29, 1991

Indexes

Not included

Website

https://www.ernexatx.com

Employees

6

Key Details

Price

$1.18(-8.53%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$582.00K(+755.88% YoY)

Annual EPS

-$48.90(-1098.53% YoY)

PE ratio

-

Next earnings date

Nov 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.18
    ERNA price is $1.18

    30-Day Relative Volume

    2.89
    ERNA 30-day relative volume is 2.89

    Price Performance

    Price Most recent change

    -8.53%
    ERNA price was down -8.53% on Sep 15, 2025

    Price YTD change

    -72.87%
    ERNA price is down -72.87% since January 1st

    Price 1-year change

    -94.76%
    ERNA price is down -94.76% year-on-year

    Price 3-year change

    -98.84%
    ERNA price is down -98.84% over the past 3 years

    Price Range

    Price All-time high

    $345.00K
    ERNA price is currently -100.00% below its historical high of $345.00 thousand

    Price 3-year low

    $1.17
    ERNA price is currently +0.85% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $8.69M
    ERNA market capitalization is $8.69 million

    Market cap 3-year change

    -56.57%
    ERNA market capitalization is down -56.57% over the past 3 years

    Market cap All-time high

    $120.58B
    ERNA market capitalization is currently -99.99% below its historical high of $120.58 billion

    Market cap sector rank

    13.26%
    ERNA market capitalization is higher than 13.26% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1940.81%
    ERNA shares outstanding is up +1940.81% year-on-year

    Shares Outstanding 3-Year Change

    +3653.8%
    ERNA shares outstanding is up +3653.8% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.37
    ERNA beta is 1.37

    200-day SMA

    $3.42
    ERNA price is currently -65.54% below its 200-day simple moving average

    50-day SMA

    $1.65
    ERNA price is currently -28.55% below its 50-day simple moving average

    RSI

    32.31
    ERNA 14-day relative strength index is 32.31

    Volume

    2.89
    ERNA 30-day relative volume is 2.89

    ATR

    $0.14
    ERNA average true range is $0.14

    10-day Historical Volatility

    90.68%
    ERNA 10-day historical volatility is 90.68%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $582.00K
    ERNA annual revenue is $582.00 thousand

    Revenue Analysts estimate

    -
    ERNA annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    +755.88%
    ERNA annual revenue is up +755.88% year-on-year

    Revenue Sector rank

    35.36%
    ERNA annual revenue is higher than 35.36% of companies in Healthcare sector

    EPS

    EPS

    -$48.90
    ERNA annual earnings per share is -$48.90

    EPS Analysts estimate

    -
    ERNA annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -1098.53%
    ERNA annual earnings per share is down -1098.53% year-on-year

    EPS Sector rank

    4.7%
    ERNA annual earnings per share is higher than 4.7% of companies in Healthcare sector

    Profit

    Gross profit

    -$1.15M
    ERNA annual gross profit is -$1.15 million

    Gross margin

    -197.94%
    ERNA annual gross profit margin is -197.94%

    Operating profit

    -$17.25M
    ERNA annual operating income is -$17.25 million

    Operating margin

    -2963.92%
    ERNA annual operating profit margin is -2963.92%

    Net income

    -$44.54M
    ERNA annual net profit is -$44.54 million

    Net margin

    -7652.75%
    ERNA annual net profit margin is -7652.75%

    Expenses

    Total expenses

    $45.12M
    ERNA annual total expenses is $45.12 million

    Operating expenses

    $16.10M
    ERNA annual total operating expenses is $16.10 million

    Cost of goods sold

    $1.73M
    ERNA annual cost of goods sold is $1.73 million

    Selling, general & administrative expenses

    $0.00
    ERNA annual SGA is $0.00

    Depreciation and amortization

    $1.64M
    ERNA annual depreciation & amortization is $1.64 million

    Interest expense

    $0.00
    ERNA annual interest expense is $0.00

    Income tax

    $30.00K
    ERNA annual income tax is $30.00 thousand

    EBIT & EBITDA

    EBIT

    -$17.25M
    ERNA annual earnings before interest & taxes is -$17.25 million

    EBITDA

    -$15.61M
    ERNA annual EBITDA is -$15.61 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $5.27M
    ERNA annual total assets is $5.27 million

    Non current assets

    $2.92M
    ERNA annual long term assets is $2.92 million

    Current assets

    $2.35M
    ERNA annual total current assets is $2.35 million

    Cash and cash equivalents

    $1.73M
    ERNA annual cash & cash equivalents is $1.73 million

    Accounts receivable

    -
    ERNA annual accounts receivable value is unknown

    Inventory

    $0.00
    ERNA annual inventory is $0.00

    Liabilities

    Total liabilities

    $3.57M
    ERNA annual total liabilities is $3.57 million

    Long term liabilities

    $630.00K
    ERNA annual total long term liabilities is $630.00 thousand

    Current liabilities

    $2.94M
    ERNA annual total current liabilities is $2.94 million

    Accounts payable

    $1.72M
    ERNA annual accounts payable is $1.72 million

    Debt

    Total debt

    $684.00K
    ERNA annual total debt is $684.00 thousand

    Total debt 1-year change

    -98.37%
    ERNA annual total debt is down -98.37% year-on-year

    Long term debt

    $477.00K
    ERNA annual long term debt is $477.00 thousand

    Short term debt

    $207.00K
    ERNA annual short term debt is $207.00 thousand

    Equity & Capital

    Shareholders equity

    $1.70M
    ERNA annual stockholders equity is $1.70 million

    Book value

    $25.50M
    ERNA annual book value is $25.50 million

    Retained earnings

    -$231.54M
    ERNA annual retained earnings is -$231.54 million

    Working capital

    -$586.00K
    ERNA annual working capital is -$586.00 thousand

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$15.84M
    ERNA annual cash flow from operations is -$15.84 million

    Cash from operations 1-year change

    +22.4%
    ERNA annual cash flow from operations is up +22.4% year-on-year

    Cash from investing

    -$365.00K
    ERNA annual cash flow from investing activities is -$365.00 thousand

    Cash from investing 1-year change

    -1821.05%
    ERNA annual cash flow from investing activities is down -1821.05% year-on-year

    Cash from financing

    $6.26M
    ERNA annual cash flow from financing activities is $6.26 million

    Cash from financing 1-year change

    -62.19%
    ERNA annual cash flow from financing activities is down -62.19% year-on-year

    CAPEX

    CAPEX

    $369.00K
    ERNA annual capital expenditures is $369.00 thousand

    CAPEX 1-year change

    +1842.11%
    ERNA annual capital expenditures is up +1842.11% year-on-year

    Free Cash Flow

    Free cash flow

    -$16.20M
    ERNA annual free cash flow is -$16.20 million

    Free cash flow 1-year change

    +20.67%
    ERNA annual free cash flow is up +20.67% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -197.94%
    ERNA annual gross profit margin is -197.94%

    Operating margin

    -2963.92%
    ERNA annual operating profit margin is -2963.92%

    Net margin

    -7652.75%
    ERNA annual net profit margin is -7652.75%

    ROA & ROE

    ROA

    -163.74%
    ERNA annual return on assets is -163.74%

    ROE

    -2264.31%
    ERNA annual return on equity is -2264.31%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ERNA price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ERNA price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.96
    ERNA price to book ratio is 1.96

    PB ratio Sector rank

    53.03%
    ERNA price to book ratio is higher than 53.03% of companies in Healthcare sector

    PS Ratio

    PS ratio

    17.80
    ERNA price to sales ratio is 17.80

    PS ratio Sector rank

    79.46%
    ERNA price to sales ratio is higher than 79.46% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $4.96M
    ERNA enterprise value is $4.96 million

    Enterprise value Sector rank

    17.6%
    ERNA enterprise value is higher than 17.6% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.45
    ERNA EV/EBITDA is -0.45

    EV/EBITDA Sector rank

    54.89%
    ERNA EV/EBITDA is higher than 54.89% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.80
    ERNA annual current ratio is 0.80

    Quick ratio

    0.80
    ERNA annual quick ratio is 0.80

    Leverage

    Debt to equity

    0.40
    ERNA annual debt to equity ratio is 0.40

    Interest coverage ratio

    -
    ERNA annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ERNA piotroski f-score value is unknown

    Altman Z-Score

    -70.89
    ERNA altman z-score is -70.89

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with ERNA included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Stocks recommended to hold
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for Ernexa Therapeutics Inc.?
    • Does Ernexa Therapeutics Inc. pay dividends?
    • What sector is Ernexa Therapeutics Inc. in?
    • What industry is Ernexa Therapeutics Inc. in?
    • What country is Ernexa Therapeutics Inc. based in?
    • When did Ernexa Therapeutics Inc. go public?
    • Is Ernexa Therapeutics Inc. in the S&P 500?
    • Is Ernexa Therapeutics Inc. in the NASDAQ 100?
    • Is Ernexa Therapeutics Inc. in the Dow Jones?
    • When was Ernexa Therapeutics Inc.'s last earnings report?
    • When does Ernexa Therapeutics Inc. report earnings?

    What is the ticker symbol for Ernexa Therapeutics Inc.?

    The ticker symbol for Ernexa Therapeutics Inc. is NASDAQ:ERNA

    Does Ernexa Therapeutics Inc. pay dividends?

    No, Ernexa Therapeutics Inc. does not pay dividends

    What sector is Ernexa Therapeutics Inc. in?

    Ernexa Therapeutics Inc. is in the Healthcare sector

    What industry is Ernexa Therapeutics Inc. in?

    Ernexa Therapeutics Inc. is in the Biotechnology industry

    What country is Ernexa Therapeutics Inc. based in?

    Ernexa Therapeutics Inc. is headquartered in United States

    When did Ernexa Therapeutics Inc. go public?

    Ernexa Therapeutics Inc.'s initial public offering (IPO) was on August 29, 1991

    Is Ernexa Therapeutics Inc. in the S&P 500?

    No, Ernexa Therapeutics Inc. is not included in the S&P 500 index

    Is Ernexa Therapeutics Inc. in the NASDAQ 100?

    No, Ernexa Therapeutics Inc. is not included in the NASDAQ 100 index

    Is Ernexa Therapeutics Inc. in the Dow Jones?

    No, Ernexa Therapeutics Inc. is not included in the Dow Jones index

    When was Ernexa Therapeutics Inc.'s last earnings report?

    Ernexa Therapeutics Inc.'s most recent earnings report was on August 13, 2025

    When does Ernexa Therapeutics Inc. report earnings?

    The next expected earnings date for Ernexa Therapeutics Inc. is November 12, 2025
    On this page